Hotchkis & Wiley Capital Management Has Increased Vodafone Group Plc New (VOD) Stake By $92.35 Million; Idexx Laboratories (IDXX) Shorts Lowered By 1.58%

September 4, 2017 - By Hazel Jackson

Hotchkis & Wiley Capital Management Llc increased Vodafone Group Plc New (VOD) stake by 31.03% reported in 2016Q4 SEC filing. Hotchkis & Wiley Capital Management Llc acquired 3.85M shares as Vodafone Group Plc New (VOD)’s stock rose 16.21%. The Hotchkis & Wiley Capital Management Llc holds 16.25M shares with $397.02M value, up from 12.40M last quarter. Vodafone Group Plc New now has $77.72B valuation. The stock decreased 0.62% or $0.18 on September 1, reaching $28.85. About 2.96 million shares traded or 15.18% up from the average. Vodafone Group Plc (ADR) (NASDAQ:VOD) has declined 13.23% since September 4, 2016 and is downtrending. It has underperformed by 29.93% the S&P500.

Idexx Laboratories Incorporated (NASDAQ:IDXX) had a decrease of 1.58% in short interest. IDXX’s SI was 2.21 million shares in September as released by FINRA. Its down 1.58% from 2.25M shares previously. With 441,600 avg volume, 5 days are for Idexx Laboratories Incorporated (NASDAQ:IDXX)’s short sellers to cover IDXX’s short positions. The SI to Idexx Laboratories Incorporated’s float is 2.55%. The stock decreased 0.29% or $0.45 on September 1, reaching $154.98. About 265,073 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 83.30% since September 4, 2016 and is uptrending. It has outperformed by 66.60% the S&P500.

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The company has market cap of $13.53 billion. The Firm also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. It has a 53.19 P/E ratio. The Company’s divisions include diagnostic and information technology services and products for the veterinary market, which the Company refers to as the Companion Animal Group; water quality products; diagnostic services and products for livestock and poultry health, which the Company refers to as Livestock, Poultry and Dairy, and Other operating segment, which combines and presents products for the human point-of-care medical diagnostics market with its pharmaceutical product line and its out-licensing arrangements.

Among 9 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 5 have Buy rating, 2 Sell and 2 Hold. Therefore 56% are positive. IDEXX Laboratories had 20 analyst reports since July 24, 2015 according to SRatingsIntel. Raymond James downgraded the stock to “Market Perform” rating in Friday, August 28 report. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by C.L. King on Friday, July 28. Credit Suisse maintained the stock with “Outperform” rating in Wednesday, April 13 report. The stock has “Outperform” rating by Credit Suisse on Thursday, February 4. On Thursday, October 29 the stock rating was maintained by Stifel Nicolaus with “Buy”. The stock has “Sell” rating by Feltl & Co on Friday, February 3. The firm has “Neutral” rating given on Friday, April 1 by CL King. The firm has “Buy” rating given on Wednesday, August 23 by Bank of America. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, August 13. The firm has “Buy” rating given on Tuesday, June 13 by Canaccord Genuity.

Investors sentiment increased to 1.19 in 2016 Q4. Its up 0.25, from 0.94 in 2016Q3. It increased, as 29 investors sold IDEXX Laboratories, Inc. shares while 183 reduced holdings. 67 funds opened positions while 130 raised stakes. 75.18 million shares or 3.36% less from 77.79 million shares in 2016Q3 were reported. Boston Family Office Lc invested 0.28% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Blackrock Fund Advsr has 0.08% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 3.71M shares. New York-based Williams Jones & Assocs Lc has invested 2.14% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Voya Investment Management Limited Liability has 0.03% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 109,596 shares. Virginia Retirement System Et Al owns 15,000 shares or 0.02% of their US portfolio. Moreover, Asset Management One Com has 0.05% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 169,025 shares. Bnp Paribas Arbitrage Sa stated it has 0.01% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Arizona State Retirement invested in 0.06% or 34,634 shares. Fjarde Ap holds 25,007 shares or 0.07% of its portfolio. Quantbot Tech Lp holds 0.23% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 17,609 shares. Teacher Retirement System Of Texas, a Texas-based fund reported 30,173 shares. Nebraska-based Ameritas Inv Partners Inc has invested 0.16% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Lau Assoc Ltd Liability Co owns 16,752 shares for 1.99% of their portfolio. West Coast Limited Liability holds 2.67% in IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 71,560 shares. 700 were reported by Old Mutual Customised Solutions (Proprietary).

Since May 3, 2017, it had 0 insider buys, and 5 selling transactions for $10.08 million activity. On Wednesday, May 31 the insider TWIGGE GIOVANI sold $429,272. On Friday, May 5 the insider AYERS JONATHAN W sold $4.18 million. Shares for $812,769 were sold by END WILLIAM T on Monday, May 22. The insider HENDERSON REBECCA M sold 1,700 shares worth $271,912.

Among 7 analysts covering Vodafone Group PLC (ADR) (NASDAQ:VOD), 3 have Buy rating, 1 Sell and 3 Hold. Therefore 43% are positive. Vodafone Group PLC (ADR) had 12 analyst reports since October 19, 2015 according to SRatingsIntel. Standpoint Research initiated Vodafone Group Plc (ADR) (NASDAQ:VOD) on Tuesday, January 3 with “Accumulate” rating. The stock has “Reduce” rating by Standpoint Research on Thursday, June 1. On Monday, October 19 the stock rating was upgraded by Macquarie Research to “Outperform”. As per Wednesday, August 9, the company rating was upgraded by Bank of America. The rating was upgraded by Argus Research to “Buy” on Monday, June 12. The company was downgraded on Monday, November 21 by BNP Paribas. Bank of America upgraded the stock to “Buy” rating in Wednesday, April 20 report. Bank of America downgraded the shares of VOD in report on Wednesday, January 25 to “Neutral” rating. The stock of Vodafone Group Plc (ADR) (NASDAQ:VOD) earned “Buy” rating by Goldman Sachs on Tuesday, January 10. The company was downgraded on Monday, June 13 by Macquarie Research.